TokenPost·
AstraZeneca Shares Gain 7.02%; Third-Quarter Revenue Rises 7%
Core EPS reached $2.79 per share, and a three-year restructuring program targets $1.5 billion in annualized pretax benefits.
More news
- TokenPostFour Firms Raise Microsoft Price Targets, With Two Setting $650
- TokenPostLumentum Shares Turn Lower After Premarket Trading Resumes
- TokenPostSolana Leads Tokenized-Equity DEX Trading With $977 Million
- TokenPostInformation Services Group Q3 Revenue Beats Estimate by $1.08 Million
- The DefiantZachXBT Flags Suspected $106 Million-Plus Theft From EU Entity
- Crypto BriefingMetaplanet repurchases 96.45M shares for $160M and redirects bond cash to Bitcoin